About Terrance Bruggeman
Form D filings for Avenzoar Pharmaceuticals from 2019 to 2023 list Terrance Bruggeman as chief executive officer and director.
Terrance Bruggeman first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Terrance Bruggeman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Terrance Bruggeman works with at each company, as listed on that company's latest Form D.
Avenzoar Pharmaceuticals, Inc. · Form D, Jun 16, 2023